FDA Clearance Tracker · P020024-S024
AMPLATZER DUCT OCCLUDER
Last checked: Nov 20, 2026Latest source record: Dec 23, 2010 (this decision)Source: openFDAMethods & limitations
Decided
Dec 23, 2010
Approved
Time to decision
657 days
Received Mar 6, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P020024-S024
- Device name
- AMPLATZER DUCT OCCLUDER
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Mar 6, 2009
- Decided
- Dec 23, 2010
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P020024
Device type
- Device type
- OCCLUDER, PATENT DUCTUS, ARTERIOSUS (MAE)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR UPDATES TO THE LABELING OF THE AMPLATZER DUCT OCCLUDER TO REFLECT THE FINDINGS OF THE POST APPROVAL STUDY.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.